High rates of hepatitis C virus reinfection and spontaneous clearance of reinfection in people who inject drugs: a prospective cohort study.
about
Hepatitis C virus (HCV) genotypes distribution: an epidemiological up-date in EuropeMany hepatitis C reinfections that spontaneously clear may be undetected: Markov-chain Monte Carlo analysis of observational study data.The Humoral Immune Response to HCV: Understanding is Key to Vaccine Development.Hepatitis C Virus Reinfection and Spontaneous Clearance of Reinfection--the InC3 StudyIncident Hepatitis C Virus Genotype Distribution and Multiple Infection in Australian PrisonsHepatitis C: Review of the Epidemiology, Clinical Care, and Continued Challenges in the Direct Acting Antiviral Era.HCV Cure and Reinfection Among People With HIV/HCV Coinfection and People Who Inject Drugs.HCV avidity as a tool for detection of recent HCV infection: sensitivity depends on HCV genotype.United Kingdom National Guideline on the Management of the viral hepatitides A, B and C 2015.The changing landscape of hepatitis C treatment-not 'can we cure?' but 'who should we cure first?' Is this an ethical approach?Hepatitis C cross-genotype immunity and implications for vaccine developmentThe Rationale for a Preventative HCV Virus-Like Particle (VLP) Vaccine.Understanding and addressing hepatitis C reinfection in the oral direct acting antiviral era.Immunological responses following administration of a genotype 1a/1b/2/3a quadrivalent HCV VLP vaccine.Rapid testing for hepatitis C does not infer current infectionHow "hidden" are unobserved networks among people who inject drugs?Intelligent Network DisRuption Analysis (INDRA): A targeted strategy for efficient interruption of hepatitis C transmissions
P2860
Q28079580-BFA96836-6DF0-473D-9269-75D12448C59CQ30884457-4DA4FADA-BFC6-4FF7-A5A1-ED09709FF355Q34481429-1F2B37B7-A1A9-4EAB-8C43-0C757294F2A0Q36148971-93814D7B-9FE0-40AA-A52B-565929257B15Q37040556-D2367815-2B45-448E-BE7E-236C3367D26DQ38635796-A3D6B0EA-0654-4189-B3F7-62035AF3361FQ38692113-B1B501B2-DA71-4170-A096-363E7BAFD269Q40069643-434F8F6A-90B8-4CB7-988F-360528C52523Q40990518-E1AF0787-5D12-4106-97B6-02551C10F667Q41745288-06996559-0667-423A-B74B-DFC7A85F1021Q42364607-F8EC72EF-E72B-48CA-8CBF-BAD784DA955AQ45324462-FCA2CB06-2C0D-4960-8F9D-3261C05477E9Q47274505-060B447D-928A-4D21-BC79-C23B43DF3387Q55303632-8E0B606D-52D6-4DDE-A69F-CE173BEEC4ABQ56890548-52129DCC-1DCA-42E2-942B-139673BACD8BQ56890615-E041F30A-398A-4881-8AA3-EC85FD9B7270Q57092078-2B035882-301D-4895-ACE0-E4188DA8D42E
P2860
High rates of hepatitis C virus reinfection and spontaneous clearance of reinfection in people who inject drugs: a prospective cohort study.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年学术文章
@wuu
2013年学术文章
@zh-cn
2013年学术文章
@zh-hans
2013年学术文章
@zh-my
2013年学术文章
@zh-sg
2013年學術文章
@yue
2013年學術文章
@zh
2013年學術文章
@zh-hant
name
High rates of hepatitis C viru ...... s: a prospective cohort study.
@en
High rates of hepatitis C viru ...... s: a prospective cohort study.
@nl
type
label
High rates of hepatitis C viru ...... s: a prospective cohort study.
@en
High rates of hepatitis C viru ...... s: a prospective cohort study.
@nl
prefLabel
High rates of hepatitis C viru ...... s: a prospective cohort study.
@en
High rates of hepatitis C viru ...... s: a prospective cohort study.
@nl
P2093
P2860
P50
P1433
P1476
High rates of hepatitis C viru ...... gs: a prospective cohort study
@en
P2093
Alisa E Pedrana
Jacob George
Jason Grebely
Mandvi Bharadwaj
Margaret Hellard
Scott Bowden
Tim Spelman
Usha K Nivarthi
P2860
P304
P356
10.1371/JOURNAL.PONE.0080216
P407
P577
2013-11-07T00:00:00Z